{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:44Z","timestamp":1760107304995,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.rmr.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:36:17Z","timestamp":1629934577000},"page":"816-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infection tuberculeuse latente (ITL)\u00a0: quel devenir \u00e0 5\u00a0ans des 155\u00a0ITL chez des sujets contacts r\u00e9cents de tuberculose \u00e0 examen microscopique positif\u00a0?"],"prefix":"10.1016","volume":"38","author":[{"given":"G.","family":"Cadelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Jelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2021.05.011_bib0145","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"Strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2021.05.011_bib0150","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/cid\/ciz188","article-title":"Estimated impact of World Health Organization latent tuberculosis screening guidelines in a low TB incidence region: retrospective cohort study","volume":"69","author":"Ronald","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2021.05.011_bib0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.rmr.2018.08.009","article-title":"Introduction-epidemiology of latent and active tuberculosis","volume":"35","author":"Maitre","year":"2018","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2021.05.011_bib0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rmr.2011.07.011","article-title":"Traitement des infections tuberculeuses latentes","volume":"29","author":"Fraisse","year":"2012","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2021.05.011_bib0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","volume":"179","author":"Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rmr.2021.05.011_bib0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2015.11.017","article-title":"Risk of active tuberculosis in the five years following infection.","volume":"149","author":"Trauer","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.05.011_bib0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.rmr.2012.05.003","article-title":"Comparative epidemiological study of the tuberculosis\u00a0\u2013\u00a0migrant and native subjects in Guadeloupe from 2006\u00a0to 2011","volume":"29","author":"Cadelis","year":"2012","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2021.05.011_bib0180","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ecolmodel.2005.10.045","article-title":"The role of sensitivity analysis in ecological modelling","volume":"203","author":"Cariboni","year":"2007","journal-title":"Ecolog Modell"},{"key":"10.1016\/j.rmr.2021.05.011_bib0190","doi-asserted-by":"crossref","first-page":"e0215322","DOI":"10.1371\/journal.pone.0215322","article-title":"Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients","volume":"14","author":"Martin-Sanchez","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rmr.2021.05.011_bib0195","doi-asserted-by":"crossref","first-page":"m549","DOI":"10.1136\/bmj.m549","article-title":"Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2021.05.011_bib0200","first-page":"853","article-title":"Executive Summary: Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"Payam","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2021.05.011_bib0205","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/dyr058","article-title":"The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach","volume":"40","author":"Borgdorff","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.rmr.2021.05.011_bib0210","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0215","first-page":"1112","article-title":"Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases","volume":"14","author":"Mor\u00e1n-Mendoza","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2021.05.011_bib0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","article-title":"Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam","volume":"190","author":"Sloot","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a wholeblood interferon-gamma release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0230","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01157-2016","article-title":"Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands","volume":"48","author":"Erkens","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2021.05.011_bib0235","doi-asserted-by":"crossref","first-page":"e1002824","DOI":"10.1371\/journal.pmed.1002824","article-title":"Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries","volume":"16","author":"Campbell","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0240","unstructured":"Infections tuberculeuses latentes. D\u00e9tection, prise en charge et surveillance. Haut Conseil de la Sant\u00e9 Publique. In: publique HCSP, editor; 2019. p. 1\u201393. www.hcsp.fr."},{"key":"10.1016\/j.rmr.2021.05.011_bib0245","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0250","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.tp.0000269104.22502.d2","article-title":"Isoniazid-related hepatic failure in children: a survey of liver transplantation centers","volume":"84","author":"Wu","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2021.05.011_bib0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"Fountain","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.05.011_bib0260","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.5588\/ijtld.18.0035","article-title":"Improved treatment completion with shorter treatment regimens for latent tuberculous infection","volume":"22","author":"Macaraig","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2021.05.011_bib0265","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2021.05.011_bib0270","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.rmr.2021.05.011_bib0275","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2021.05.011_bib0140","unstructured":"Enqu\u00eate autour d\u2019un cas de tuberculose - Recommandations pratiques. Haut conseil de la sant\u00e9 publique. In: publique HCSP, editor; 2013. p. 1\u201393. www.hcsp.fr."}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842521003016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842521003016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:21:42Z","timestamp":1760106102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842521003016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0761842521003016"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2021.05.011","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection tuberculeuse latente (ITL)\u00a0: quel devenir \u00e0 5\u00a0ans des 155\u00a0ITL chez des sujets contacts r\u00e9cents de tuberculose \u00e0 examen microscopique positif\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}